NFKB1 and plasma cell myeloma: CRP promotes myeloma cell survival via a CD32-dependent pathway involving PI3 kinase, ERK, and NF-κB [48], and CRP can stimulate the proliferation of U266 multiple myeloma cells by up-regulating the expression of survivin and HSP90α proteins [61].